Patents Represented by Attorney, Agent or Law Firm Charlie M. Kinzig
  • Method to enhance an immune response of nucleic acid vaccination
    Patent number: 6500432
    Abstract: This invention provides a method to enhance an immune response of nucleic acid vaccination by simultaneous administration of a polynucleotide and a polypeptide of interest.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: December 31, 2002
    Assignee: SmithKline Beecham Biologicals, S.A.
    Inventors: Wilfried Dalemans, Marcelle Van Mechelen, Claudine Bruck, Martin Friede
  • Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof
    Patent number: 6461836
    Abstract: AXOR34 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing AXOR34 polypeptides and polynucleotides in diagnostic assays. Further disclosed are screening assays to identify agonists and antagonists of the interaction between AXOR34 and its ligands, NmU-8, NmU-25, and NmU-23.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: October 8, 2002
    Assignees: SmithKline Beecham Corporation, SmithKline Beecham p.l.c.
    Inventors: Nabil Elshourbagy, Usman Shabon, Robert S. Ames, Henry S. Sarau, Lisa Vawter, David Michalovich